Mizuho reiterated an Outperform rating and $19 price target on one key healthcare stock name, telling investors the stock's recent ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE